Stroke risk in women: the role of menopause and hormone therapy
- 31 January 2012
- journal article
- review article
- Published by Elsevier BV in The Lancet Neurology
- Vol. 11 (1), 82-91
- https://doi.org/10.1016/s1474-4422(11)70269-1
Abstract
No abstract availableThis publication has 79 references indexed in Scilit:
- Health Outcomes After Stopping Conjugated Equine Estrogens Among Postmenopausal Women With Prior HysterectomyJAMA, 2011
- Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 UpdateCirculation, 2011
- Heart Disease and Stroke Statistics—2011 UpdateCirculation, 2011
- Are Changes in Cardiovascular Disease Risk Factors in Midlife Women Due to Chronological Aging or to the Menopausal Transition?Journal of the American College of Cardiology, 2009
- Relationship Between Higher Estradiol Levels and 9‐Year Mortality in Older Women: The Invecchiare in Chianti StudyJournal of the American Geriatrics Society, 2009
- Gender Differences in Stroke Incidence and Poststroke Disability in the Framingham Heart StudyStroke, 2009
- Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomesThe Lancet Neurology, 2008
- Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysisEuropean Heart Journal, 2008
- Associations of endogenous sex hormones with the vasculature in menopausal womenMenopause, 2008
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002